143 related articles for article (PubMed ID: 31071548)
1. Recent progress on the discovery of P2Y
Lu R; Zhang Z; Jiang C
Eur J Med Chem; 2019 Aug; 175():34-39. PubMed ID: 31071548
[TBL] [Abstract][Full Text] [Related]
2. Structure-Based Design of 3-(4-Aryl-1H-1,2,3-triazol-1-yl)-Biphenyl Derivatives as P2Y14 Receptor Antagonists.
Junker A; Balasubramanian R; Ciancetta A; Uliassi E; Kiselev E; Martiriggiano C; Trujillo K; Mtchedlidze G; Birdwell L; Brown KA; Harden TK; Jacobson KA
J Med Chem; 2016 Jul; 59(13):6149-68. PubMed ID: 27331270
[TBL] [Abstract][Full Text] [Related]
3. Molecular modeling of the human P2Y14 receptor: A template for structure-based design of selective agonist ligands.
Trujillo K; Paoletta S; Kiselev E; Jacobson KA
Bioorg Med Chem; 2015 Jul; 23(14):4056-64. PubMed ID: 25868749
[TBL] [Abstract][Full Text] [Related]
4. Exploring a 2-naphthoic acid template for the structure-based design of P2Y14 receptor antagonist molecular probes.
Kiselev E; Barrett MO; Katritch V; Paoletta S; Weitzer CD; Brown KA; Hammes E; Yin AL; Zhao Q; Stevens RC; Harden TK; Jacobson KA
ACS Chem Biol; 2014 Dec; 9(12):2833-42. PubMed ID: 25299434
[TBL] [Abstract][Full Text] [Related]
5. Discovery and computational studies of 2-phenyl-benzoxazole acetamide derivatives as promising P2Y
Zhou M; Wang W; Wang Z; Wang Y; Zhu Y; Lin Z; Tian S; Huang Y; Hu Q; Li H
Eur J Med Chem; 2022 Jan; 227():113933. PubMed ID: 34689072
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and anti-inflammatory evaluation of 3-amide benzoic acid derivatives as novel P2Y
Zhang Z; Hao K; Li H; Lu R; Liu C; Zhou M; Li B; Meng Z; Hu Q; Jiang C
Eur J Med Chem; 2019 Nov; 181():111564. PubMed ID: 31376563
[TBL] [Abstract][Full Text] [Related]
7. Exploration of Alternative Scaffolds for P2Y
Jung YH; Yu J; Wen Z; Salmaso V; Karcz TP; Phung NB; Chen Z; Duca S; Bennett JM; Dudas S; Salvemini D; Gao ZG; Cook DN; Jacobson KA
J Med Chem; 2020 Sep; 63(17):9563-9589. PubMed ID: 32787142
[TBL] [Abstract][Full Text] [Related]
8. Discovery of N-Substituted Acetamide Derivatives as Promising P2Y
Liu W; Mao S; Wang Y; Wang M; Li M; Sun M; Yao Y; Song C; Duan Y
J Med Chem; 2024 Jun; 67(12):10233-10247. PubMed ID: 38874515
[TBL] [Abstract][Full Text] [Related]
9. Drug-like Antagonists of P2Y Receptors-From Lead Identification to Drug Development.
Conroy S; Kindon N; Kellam B; Stocks MJ
J Med Chem; 2016 Nov; 59(22):9981-10005. PubMed ID: 27413802
[TBL] [Abstract][Full Text] [Related]
10. Structure-Guided Modification of Heterocyclic Antagonists of the P2Y
Yu J; Ciancetta A; Dudas S; Duca S; Lottermoser J; Jacobson KA
J Med Chem; 2018 Jun; 61(11):4860-4882. PubMed ID: 29767967
[TBL] [Abstract][Full Text] [Related]
11. P2Y14R for inflammation therapy: is it a promising target?
Wang Y; Duan Y
Future Med Chem; 2021 Sep; 13(18):1493-1495. PubMed ID: 34278830
[No Abstract] [Full Text] [Related]
12. Structure-Activity Relationship of Heterocyclic P2Y
Jung YH; Salmaso V; Wen Z; Bennett JM; Phung NB; Lieberman DI; Gopinatth V; Randle JCR; Chen Z; Salvemini D; Karcz TP; Cook DN; Jacobson KA
J Med Chem; 2021 Apr; 64(8):5099-5122. PubMed ID: 33787273
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, pharmacological characterization of a fluorescent agonist of the P2Y₁₄ receptor.
Kiselev E; Balasubramanian R; Uliassi E; Brown KA; Trujillo K; Katritch V; Hammes E; Stevens RC; Harden TK; Jacobson KA
Bioorg Med Chem Lett; 2015 Nov; 25(21):4733-4739. PubMed ID: 26303895
[TBL] [Abstract][Full Text] [Related]
14. Development of Potent and Selective Antagonists for the UTP-Activated P2Y
Rafehi M; Malik EM; Neumann A; Abdelrahman A; Hanck T; Namasivayam V; Müller CE; Baqi Y
J Med Chem; 2017 Apr; 60(7):3020-3038. PubMed ID: 28306255
[TBL] [Abstract][Full Text] [Related]
15. A selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophils.
Barrett MO; Sesma JI; Ball CB; Jayasekara PS; Jacobson KA; Lazarowski ER; Harden TK
Mol Pharmacol; 2013 Jul; 84(1):41-9. PubMed ID: 23592514
[TBL] [Abstract][Full Text] [Related]
16. Bridged Piperidine Analogues of a High Affinity Naphthalene-Based P2Y
Wen Z; Salmaso V; Jung YH; Phung NB; Gopinatth V; Shah Q; Patterson AT; Randle JCR; Chen Z; Salvemini D; Lieberman DI; Whitehead GS; Karcz TP; Cook DN; Jacobson KA
J Med Chem; 2022 Feb; 65(4):3434-3459. PubMed ID: 35113556
[TBL] [Abstract][Full Text] [Related]
17. Tools and drugs for uracil nucleotide-activated P2Y receptors.
Rafehi M; Müller CE
Pharmacol Ther; 2018 Oct; 190():24-80. PubMed ID: 29660366
[TBL] [Abstract][Full Text] [Related]
18. The role of P2Y
Zhou M; Wang W; Li Y; Zhang Q; Ji H; Li H; Hu Q
Drug Discov Today; 2020 Mar; 25(3):568-573. PubMed ID: 31926135
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the development of P2Y
Wang K; Zhong F; Zhang ZD; Li HQ; Tian S
Expert Opin Ther Pat; 2024 Jun; ():1-15. PubMed ID: 38889204
[TBL] [Abstract][Full Text] [Related]
20. Breakthrough in GPCR Crystallography and Its Impact on Computer-Aided Drug Design.
Ciancetta A; Jacobson KA
Methods Mol Biol; 2018; 1705():45-72. PubMed ID: 29188558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
